The Apex Femoral Nailing System Receives US FDA 510(k) Clearance
OrthoXel™ is delighted to announce that the new Apex Femoral Nailing System has been granted US FDA 510(k) clearance, following regulatory clearances and first clinical implantations of the Apex Tibial Nailing System earlier this year.
CUH Study Principal Investigator
OrthoXel Chief Medical Officer
Professor James Harty is a Professor of Orthopedic Surgery at UCC and is currently working across three institutions – Cork University Hospital, South infirmary Victoria University Hospital and the Bon Secours Hospital in Cork, Ireland. He has practiced orthopaedic surgery for over 17 years and is a Fellow of the Royal College of Surgeons in Ireland.
Recent Posts
New White Paper: Fracture Healing Following Delayed Weight Bearing in High-Energy Tibial Fractures Treated with Apex Micromotion Fixation
Clinical Study Insights: Early Experience with the Apex Tibial Nail | Dr. Joseph Johnson
Building Momentum in 2026: Distributor Training, Clinical Leadership & Research Excellence
Newly Published Peer-Reviewed Case Series on the Apex Tibial Nail
OTA 2025 Recap: Highlights, Insights & Connections from Phoenix
